MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 179 filers reported holding MERIDIAN BIOSCIENCE INC in Q4 2017. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $2,206,000 | -6.3% | 148,100 | 0.0% | 0.13% | -8.7% |
| Q2 2018 | $2,354,000 | +11.9% | 148,100 | 0.0% | 0.14% | +3.0% |
| Q1 2018 | $2,103,000 | -27.3% | 148,100 | -28.3% | 0.13% | -13.5% |
| Q4 2017 | $2,891,000 | +18.4% | 206,500 | +20.9% | 0.16% | +18.3% |
| Q3 2017 | $2,442,000 | +51.3% | 170,800 | +66.7% | 0.13% | +31.0% |
| Q2 2017 | $1,614,000 | +14.1% | 102,483 | 0.0% | 0.10% | +12.4% |
| Q1 2017 | $1,414,000 | +145.1% | 102,483 | +214.4% | 0.09% | +89.4% |
| Q4 2016 | $577,000 | +58.1% | 32,600 | +66.3% | 0.05% | -7.8% |
| Q2 2015 | $365,000 | -2.1% | 19,600 | 0.0% | 0.05% | -1.9% |
| Q1 2015 | $373,000 | +15.8% | 19,600 | 0.0% | 0.05% | -3.7% |
| Q4 2014 | $322,000 | -41.2% | 19,600 | -36.8% | 0.05% | -34.1% |
| Q3 2014 | $548,000 | -14.2% | 31,000 | 0.0% | 0.08% | -13.7% |
| Q2 2014 | $639,000 | +88.5% | 31,000 | +98.7% | 0.10% | +79.2% |
| Q1 2014 | $339,000 | -54.5% | 15,600 | -44.5% | 0.05% | -58.9% |
| Q4 2013 | $745,000 | – | 28,100 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
| Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
| FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
| Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
| FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
| HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
| Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
| Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
| Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |